Copyright
©The Author(s) 2022.
World J Clin Cases. Feb 16, 2022; 10(5): 1485-1497
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1485
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1485
Characteristics | All-cause survival (CI) | P value | Gastric cancer-specific survival (CI) | P value |
Age (yr) | ||||
< 65 | 1.08 (1.00, 1.18) | 0.064 | 0.77 (0.69, 0.85) | < 0.001 |
≥ 65 | 1.00 (0.96, 1.04) | 0.843 | 0.83 (0.79, 0.87) | < 0.001 |
Stage | ||||
Localized | 1.10 (1.02, 1.19) | 0.012 | 0.82 (0.74, 0.91) | < 0.001 |
Regional | 0.99 (0.92, 1.06) | 0.777 | 0.84 (0.78, 0.92) | < 0.001 |
Distant | 0.92 (0.87, 0.98) | 0.014 | 0.79 (0.73, 0.85) | < 0.001 |
Timing of prior cancer | ||||
< 5 | 1.03 (0.98, 1.09) | 0.275 | 0.77 (0.72, 0.82) | < 0.001 |
5-10 | 0.98 (0.92, 1.04) | 0.525 | 0.84 (0.78, 0.90) | < 0.001 |
≥ 10 | 1.01 (0.94, 1.08) | 0.811 | 0.88 (0.81, 0.95) | 0.001 |
- Citation: Yin X, He XK, Wu LY, Yan SX. Effect of prior malignancy on the prognosis of gastric cancer and somatic mutation. World J Clin Cases 2022; 10(5): 1485-1497
- URL: https://www.wjgnet.com/2307-8960/full/v10/i5/1485.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i5.1485